Medication info
Telmisartan/Esamlodipine Besilate Hydrate 80/5mg Tablet

Telmisartan/Esamlodipine Besilate Hydrate 80/5mg Tablet

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletS-Amlodipine Besylate Dihydrate›7.38mg / 1 tablet
Manufacturer / importer
Jongkundang Co., Ltd.
Appearance
Egg-shaped tablets consisting of two layers, pale yellow and blue
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201507273 · Approved 2015.10.22 · Insurance code 643307290

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medication is 1 tablet once daily, taken with water regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medication, it is recommended that the dose be adjusted using the individual components (telmisartan or S-amlodipine (amlodipine)); however, a direct switch to this medication may be considered if blood pressure is not controlled with the individual components, as follows. - 40/2.5 milligrams: For patients whose blood pressure is not adequately controlled with S-amlodipine 2.5 milligrams (amlodipine 5 milligrams) or telmisartan 40 milligrams. - 80/2.5 milligrams: For patients whose blood pressure is not adequately controlled with S-amlodipine 2.5 milligrams (amlodipine 5 milligrams). - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with telmisartan 40 milligrams or 80 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with telmisartan 80 milligrams or this medication 40/5 milligrams. Patients taking telmisartan and S-amlodipine (amlodipine) concomitantly may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience. ◦ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. However, for patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section '3. Patients for whom administration requires caution'). For older adults aged 75 years and over, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
Child dose
The safety and efficacy of this medication have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Jongkundang Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

Telmisartan or esamlodipine (amlodipine) is used when blood pressure is not sufficiently controlled in patients with essential hypertension with monotherapy. These medications effectively lower blood pressure and help reduce the risk of cardiovascular diseases. Each component works by dilating blood vessels to reduce blood pressure and can be used alone or in combination as needed. It is important to take the medication continuously at the appropriate dosage as per the patient's condition.

How to take

Adult dose

The recommended dose of this medication is 1 tablet once daily, taken with water regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medication, it is recommended that the dose be adjusted using the individual components (telmisartan or S-amlodipine (amlodipine)); however, a direct switch to this medication may be considered if blood pressure is not controlled with the individual components, as follows. - 40/2.5 milligrams: For patients whose blood pressure is not adequately controlled with S-amlodipine 2.5 milligrams (amlodipine 5 milligrams) or telmisartan 40 milligrams. - 80/2.5 milligrams: For patients whose blood pressure is not adequately controlled with S-amlodipine 2.5 milligrams (amlodipine 5 milligrams). - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with telmisartan 40 milligrams or 80 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with telmisartan 80 milligrams or this medication 40/5 milligrams. Patients taking telmisartan and S-amlodipine (amlodipine) concomitantly may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience. ◦ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. However, for patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section '3. Patients for whom administration requires caution'). For older adults aged 75 years and over, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.

Child dose

The safety and efficacy of this medication have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Precautions

This drug can cause serious harm to the fetus during pregnancy, especially in the second and third trimesters, so it should not be used by pregnant women or women who may become pregnant. Patients with allergies to ingredients in this medication or those with specific liver, heart, or kidney diseases should avoid taking it. Patients with impaired liver or kidney function should use caution as it may affect the metabolism and excretion of the drug, and dosage adjustments may be needed as appropriate. Patients with gastrointestinal diseases should be cautious while taking this drug as it can cause side effects like gastrointestinal bleeding. This drug has the effect of lowering blood pressure, so hypotensive symptoms may occur; in such cases, it is important to lie down and rest immediately and seek medical treatment if necessary. There is a risk of increased potassium levels in the blood, so it is essential to consult a physician when taking potassium-rich foods or potassium supplements. Patients with decreased kidney function may experience further deterioration of kidney function when taking this drug, so regular blood tests and monitoring by a doctor are needed. Patients with heart disease or angina should be cautious as symptoms may worsen when taking this drug. This medication can cause drowsiness or dizziness, so caution is necessary when driving or operating hazardous machinery. Interactions may occur when this drug is taken in combination with other antihypertensive medications or specific drugs, so it is important to inform the doctor or pharmacist about any medications being taken. Women who are pregnant or breastfeeding should avoid taking this drug, and if planning a pregnancy, it is advisable to switch to another safe treatment. The safety and efficacy of this drug have not been sufficiently established in children under 18 years of age, and its use is not recommended. Older adults may be more sensitive to the medication, so starting with a lower dose and gradually increasing it is safer. In case of overdose, symptoms such as hypotension, dizziness, and heart problems may occur, so immediate medical attention should be sought. This drug should be kept out of the reach of children, and it is important not to transfer it to another container to maintain the quality of the medication.

Side effects

  • Headache
  • peripheral edema
  • swelling
  • palpitations
  • dizziness
  • increased SGOT
  • nausea
  • increased platelet count
  • facial flushing
  • localized edema
Show 99 more
  • upper respiratory infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • anxiety
  • confusion
  • drowsiness
  • migraine
  • sensory disturbance
  • syncope
  • peripheral neuropathy
  • taste disturbance
  • tremors
  • extrapyramidal disorder
  • muscle hypertonia
  • visual impairment
  • vertigo
  • tinnitus
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • shortness of breath
  • rhinitis
  • change in bowel habits
  • abdominal pain
  • dyspepsia
  • nausea
  • diarrhea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • pancreatitis
  • gastritis
  • liver dysfunction
  • liver impairment
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • phototoxic reaction
  • toxic epidermal necrolysis
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • urinary disorders
  • frequent urination
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. This will help maintain the drug's efficacy and safety.

Appearance and packaging

Appearance

Egg-shaped tablets consisting of two layers, pale yellow and blue

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.